➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
McKinsey
Mallinckrodt
Express Scripts
Dow

Last Updated: May 28, 2020

DrugPatentWatch Database Preview

Kanamycin sulfate - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for kanamycin sulfate and what is the scope of freedom to operate?

Kanamycin sulfate is the generic ingredient in four branded drugs marketed by Apothecon, West-ward Pharms Int, Abraxis Pharm, Fresenius Kabi Usa, Intl Medication, Loch, Pharmafair, Solopak, Warner Chilcott, Watson Labs, and King Pharms, and is included in twenty NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for kanamycin sulfate.

Summary for kanamycin sulfate
US Patents:0
Tradenames:4
Applicants:11
NDAs:20
Drug Master File Entries: 5
Bulk Api Vendors: 87
Patent Applications: 6,931
DailyMed Link:kanamycin sulfate at DailyMed
Medical Subject Heading (MeSH) Categories for kanamycin sulfate
Synonyms for kanamycin sulfate
(1S,2R,3R,4S,6R)-4,6-diamino-3-(6-amino-6-deoxy-alpha-D-glucopyranosyloxy)-2-hydroxycyclohexyl 3-amino-3-deoxy-alpha-D-glucopyranoside
(1S,2R,3R,4S,6R)-4,6-diamino-3-[(6-amino-6-deoxy-alpha-D-glucopyranosyl)oxy]-2-hydroxycyclohexyl 3-amino-3-deoxy-alpha-D-glucopyranoside
(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-(((1R,2R,3S,4R,6S)-4,6-diamino-3-(((2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)te
(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-((1R,2R,3S,4R,6S)-4,6-diamino-3-((2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-2-hydroxycyclohexyloxy)tetrahydro-2H-pyran-3,4,5-triol
(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-((1R,2R,3S,4R,6S)-4,6-diamino-3-((2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-2-hydroxycyclohexyloxy)tetrahydro-2H-pyran-3,4,5-triol sulfate
(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-bis(azanyl)-3-[(2S,3R,4S,5S,6R)-4-azanyl-6-(hydroxymethyl)-3,5-bis(oxidanyl)oxan-2-yl]oxy-2-oxidanyl-cyclohexyl]oxy-oxane-3,4,5-triol sulphate
(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol;sulfuric acid
(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]tetrahydropyran-3,4,5-triol
(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-{[(1R,2R,3S,4R,6S)-4,6-diamino-3-{[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}oxane-3,4,5-triol
133-92-6
133K926
25389-94-0
3847-27-6
4,6-Diamino-2-hydroxy-1,3-cyclohexane 3,6'diamino-3,6'-dideoxydi-alpha-D-glucoside
4,6-diamino-2-hydroxy-1,3-cyclohexylene 3,6'-diamino-3,6'-dideoxydi-D-glucopyranoside
59-01-8
8063-07-8
AB00513827
AK163185
AKOS025293505
AKOS025310124
API0003071
API0003073
API0003074
AS-14003
BDBM50031282
BIK0126
BPBio1_000669
BRD-K08327065-065-01-9
BRN 0061647
BSPBio_000607
C01822
C08046
C18H36N4O11
C18H36N4O11 .H2O4S
C18H36N4O11.H2SO4
Cantrex
CAS-25389-94-0
CCG-220394
CHEBI:17630
CHEBI:6109
CHEMBL1384
CHEMBL1446
Cristalomicina
CS-1140
CTK8G0428
D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1->6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1->4))-2-deoxy-
D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-4))-2-deoxy-
D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1,4))-2-deoxy-
D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1.fwdarw.6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1.fwdarw.4))-2-deoxy-
D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl(1->6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl(1->4))-2-deoxy-, sulfate (1:1) (salt)
D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl(1-6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl(1-4))-2-deoxy-, sulfate (1:1) (salt)
D00866
D03262
DB01172
DivK1c_000024
DSSTox_CID_27524
DSSTox_GSID_47524
DSSTox_RID_82394
DTXSID1047524
DTXSID3023184
EINECS 200-411-7
EINECS 223-347-1
EINECS 246-933-9
EQK9Q303C5
Glucopyranoside, 4,6-diamino-2-hydroxy-1,3-cyclohexylene 3,6'-diamino-3,6'-dideoxydi-, D-
HMS2096O09
HMS3713O09
HMS500B06
HSDB 3107
HY-16566A
IDI1_000024
J10342
J80EX28SMQ
K0047
K434
KAN
Kanabristol
Kanacedin
Kanamicina
Kanamicina [Italian]
kanamycin
Kanamycin (sulfate)
Kanamycin [INN:BAN]
KANAMYCIN A
Kanamycin A monosulfate
Kanamycin A sulfate
Kanamycin A sulphate
Kanamycin acid sulfate
Kanamycin Base
Kanamycin monosulfate
Kanamycin monosulfate (JP17)
Kanamycin monosulfate [JAN]
Kanamycin solution from Streptomyces kanamyceticus, 10 mg/mL in 0.9% NaCl, sterile-filtered, BioReagent, suitable for cell culture
Kanamycin solution from Streptomyces kanamyceticus, 50 mg/mL in 0.9% NaCl, BioReagent, liquid, sterile-filtered, suitable for cell culture
Kanamycin sulfate (JP17)
Kanamycin sulfate (TN)
Kanamycin sulfate (USP)
Kanamycin sulfate [USP:JAN]
Kanamycin sulfate from Streptomyces kanamyceticus, Animal Component-free
Kanamycin sulfate from Streptomyces kanamyceticus, meets USP testing specifications, powder
Kanamycin sulfate from Streptomyces kanamyceticus, powder, BioReagent, suitable for cell culture, suitable for plant cell culture
Kanamycin sulfate Streptomyces kanamyceticus, powder, gamma-irradiated
Kanamycin sulfate, Antibiotic for Culture Media Use Only
Kanamycin sulfate, mixture of Kanamycin A (main component) and Kanamycin B and C
Kanamycin Sulfate, Pharmaceutical Secondary Standard; Certified Reference Material
Kanamycin sulphate
Kanamycin-sulfate(Kantrex)
KANAMYCIN, SULFATE (1:1) (salt)
Kanamycin,(S)
Kanamycine
Kanamycine [INN-French]
Kanamycinum
Kanamycinum [INN-Latin]
Kanamytrex
Kanaqua
Kanasig
Kanatrol
Kanescin
Kanicin
Kannasyn
Kano
Kantrex (1:1 sulfate)
Kantrex (TN)
Kantrim
KBio1_000024
Klebcil (1:1 sulfate)
KM (the Antibiotic)
KM0269
KSC-27-052C
KUC109575AC
Liposomal Kanamycin
LS-146900
NCGC00016792-01
NCGC00179506-01
NCGC00260363-01
NINDS_000024
O-3-Amino-3-deoxy-.alpha.-D-glucopyranosyl-(1->6)-O-[6-amino-6-deoxy-.alpha.-D-glucopyranosyl-(1->4)]-2-deoxy-D-streptamine
O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1->6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1->4))-2-deoxy-D-streptamine
O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1->6)-O-[6-amino-6-deoxy-alpha-D-glucopyranosyl-(1->4)]-2-deoxy-D-streptamine Monosulfate
OOYGSFOGFJDDHP-KMCOLRRFSA-N
Ophtalmokalixan
Otokalixin
Prestwick3_000394
Q27094615
Q27107073
s2315
SBUJHOSQTJFQJX-NOAMYHISSA-N
SCHEMBL2735
SCHEMBL65538
SMP2_000007
ST24047464
Tox21_110612
Tox21_202817
trahydro-2H-pyran-3,4,5-triol sulfate
UNII-EQK9Q303C5
UNII-J80EX28SMQ
UNII-OW1N4G4R9W component OOYGSFOGFJDDHP-KMCOLRRFSA-N
UNII-RUC37XUP2P component SBUJHOSQTJFQJX-NOAMYHISSA-N
W-5066
ZINC8214590
ZX-AFC000777

US Patents and Regulatory Information for kanamycin sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Loch KANAMYCIN SULFATE kanamycin sulfate INJECTABLE;INJECTION 063022-001 Jul 31, 1992 DISCN No No   Start Trial   Start Trial   Start Trial
Fresenius Kabi Usa KANAMYCIN SULFATE kanamycin sulfate INJECTABLE;INJECTION 065111-002 Dec 17, 2002 DISCN No No   Start Trial   Start Trial   Start Trial
Apothecon KANTREX kanamycin sulfate CAPSULE;ORAL 062726-001 Mar 6, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Apothecon KANTREX kanamycin sulfate INJECTABLE;INJECTION 061655-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
McKinsey
Mallinckrodt
Express Scripts
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.